Bay Harbor Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$273K Buy
228
+3
+1% +$3.06K 0.06% 57
2026
Q1
$207K Buy
225
+7
+3% +$7.1K 0.05% 55
2025
Q4
$234K Buy
218
+23
+12% +$22K 0.06% 55
2025
Q3
$149K Buy
195
+17
+10% +$12.7K 0.04% 64
2025
Q2
$139K Buy
178
+47
+36% +$36.5K 0.04% 64
2025
Q1
$108K Buy
131
+9
+7% +$7.49K 0.03% 67
2024
Q4
$94.2K Buy
122
+30
+33% +$24.8K 0.03% 76
2024
Q3
$81.5K Sell
92
-4
-4% -$3.6K 0.03% 77
2024
Q2
$86.9K Hold
96
– – 0.03% 75
2024
Q1
$74.7K Buy
96
+21
+28% +$14.9K 0.03% 88
2023
Q4
$43.7K Buy
+75
New +$43.8K 0.02% 105
2021
Q1
– Sell
-22
Closed -$4K – 337
2020
Q4
$4K Buy
+22
New +$3.29K ﹤0.01% 297

Other funds holding LLY

Bay Harbor Wealth Management's LLY Position: Q2 2026 in Review

Bay Harbor Wealth Management increased its Eli Lilly (LLY) stake by 1.3% in Q2 2026, buying an estimated $3.06K and bringing the position to 228 shares worth $273K. The position accounts for 0.06% of the portfolio, ranked #57.

Bay Harbor Wealth Management first reported a position in LLY in Q4 2020 and has held it in 12 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Bay Harbor Wealth Management held 228 shares of Eli Lilly worth $273K as of Q2 2026.
  • Bay Harbor Wealth Management bought 3 Eli Lilly shares in Q2 2026, an estimated $3.06K.
  • Eli Lilly made up 0.06% of Bay Harbor Wealth Management's portfolio in Q2 2026, its #57 holding.
  • Bay Harbor Wealth Management first reported a position in Eli Lilly in Q4 2020 and has held it in 12 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bay Harbor Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.